Linike Medical Group Ltd. (LNMG)

Linike Medical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Total Valuation

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Oct 31, 2013	Oct 31, 2012
Market Capitalization	3	8	-
Market Cap Growth	-66.00%	-	-
Enterprise Value	-	8	-
Last Close Price	0.01	5.00	-

Price Ratios

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Oct 31, 2013	Oct 31, 2012
PB Ratio	-	-16.35	-

Financial Efficiency

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Oct 31, 2013	Oct 31, 2012
Net Debt / Equity Ratio	0	0.01	0.04
Net Debt / EBITDA Ratio	0	0.01	-
Quick Ratio	0	0.01	0.03
Current Ratio	0	0.01	0.21
Return on Assets (ROA)	-172.42%	-2698.88%	-
Return on Capital Employed (ROCE)	57.20%	88.50%	178.40%

Yields

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Oct 31, 2013	Oct 31, 2012
Earnings Yield	-1844.53%	-5.44%	-
Buyback Yield / Dilution	-185.78%	-535.30%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 15, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error